生脉注射液对慢性阻塞性肺病患者呼吸功能的疗效观察

目的：探讨生脉注射液对慢性阻塞性肺病患者呼吸功能的影响。方法：治疗组（２０例）在西医常规治疗的基础上，静脉滴注生脉注射液共１４天，测定治疗前后肺活量、用力肺活量（ＦＶＣ）、等１秒用力呼气容积（ＦＥＶ１）、ＦＥＶ１占ＦＶＣ比值（ＦＥＶ１／ＦＶＣ）、最大通气量、最大吸气压、负荷呼吸时间、动脉血气分析和Ｂｏｒｇ呼吸困难评分，并作治疗前后自身对照和与西医常规治疗对照组比较分析。结果：除ＦＶＣ和ＦＥＶ１／Ｆ

Therapeutic Effect of Shengmai Injection on Respiratory Function in Chronic Obstructive Pulmonary Disease

objective To explore the therapeutic effect of Shengmai injection (SMI) on respiratory function in chronic obstructive pulmonary disease (COPD). Methods: Twenty patients with COPD were continuously treated with SMI by intravenous drip in 14 days and examined the lung vital capacity (VC), forced vital capacity (FVC), forced vital capacity of the first second (FEV 1), FEV 1/FVC, maximum voluntory ventilation (MVV), maximum inspiratory pressure (MIP), load respiratory time (LT), 6 minute walk distance (6 MWD), arterial blood gas analysis, and Borg dyspnea scale before and after treatment respectively and compared with itself or control group. Results: After treatment all parameters of the treatment group were better than those of control group or itself before treatment except for FVC and FEV 1/FVC. There were significant difference (P<0 05). Conclusion: SMI can improve respiratory function in COPD. So it is an effective rehabilitative measure in treating COPD.